Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
Dickstein, Yaakov; Geffen, Yuval; Andreassen, Steen; Leibovici, Leonard; Paul, Mical.
Antimicrob Agents Chemother
; 60(8): 4717-21, 2016 08.
Artigo em Inglês | MEDLINE | ID: mdl-27216064
Documentos relacionados
Non-molecular detection of carbapenemases in Enterobacteriaceae clinical isolates.
Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-ß-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
Efficacy of ß-Lactam/ß-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-ß-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia.
Development of selective medium for IMP-type carbapenemase-producing Enterobacteriaceae in stool specimens.
Natural history and decolonization strategies for ESBL/carbapenem-resistant Enterobacteriaceae carriage: systematic review and meta-analysis.
Colonization and infection with extended-spectrum ß-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Carbapenemase-producing Enterobacteriaceae.
Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms - United States, 2006-2017.
AmpC ß-lactamase-producing Enterobacterales: what a clinician should know.